Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02364960 · ClinicalTrials.gov registry record
Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)
A clinical trial, sponsored by TriHealth.
- Terminated
- Registry status
- 16
- Enrollment target
NCT02364960 is a clinical trial that was terminated before completion, run by TriHealth. The registered enrollment target is 16 participants.
The verdict
NCT02364960 was terminated before completion, sponsored by TriHealth.
- TERMINATED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to create a registry to evaluate the use of intra-operative radiation therapy (IORT) and to study the efficacy and toxicity of breast radiotherapy given intra-operatively as a single fraction after breast conserving surgery,
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02364960
The ClinicalTrials.gov registry entry for NCT02364960 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02364960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02364960 about?
NCT02364960 is a clinical study titled "Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)". The purpose of this study is to create a registry to evaluate the use of intra-operative radiation therapy (IORT) and to study the efficacy and toxicity of breast radiotherapy given intra-operatively as a single fraction after breast conserving surgery,
What is the current status of trial NCT02364960?
This trial is currently terminated. The enrollment target is 16 participants. The study started on 2015-01. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT02364960?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.